Trial intelligence / Profile preview

Esomeprazole for early-onset preeclampsia

ChiCTR1900026972Phase 2Recruiting

Sponsor
Shanghai First Maternal and Infant Health Hospital
Start
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of esomeprazole in preeclampsia (2 arms), sponsored by Shanghai First Maternal and Infant Health Hospital. Primary endpoint: Gestational weeks. Started Jan 2020; status: recruiting.

02

Drugs

esomeprazole
03

Conditions

preeclampsia

Beyond the preview

Go deeper on ChiCTR1900026972.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900026972.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call